A dvances in cardiovascular testing have enhanced physicians' ability to diagnose and treat coronary heart disease (CHD), but increased use of these technologiesparticularly those involving radiologic imaging-has been at the epicenter of debates about rising health care costs (1) , inappropriate use (2) , and patient safety in the context of radiation exposure (3) . The controversy has also spurred public and private action, with recent years witnessing reductions in Medicare reimbursement for cardiac imaging studies (4) , adoption of prior authorization policies (5) , and promotion of professional society campaigns aimed at reducing wasteful health care services (6, 7) . Cardiac stress testing, especially when done with imaging, has been a focal point of these debates (6, 8 -11) . However, little is known about national patterns of cardiac stress test use in the United States (12) ; the extent to which test growth may be attributable to changing population demographics, risk factors, and provider characteristics; or whether racial/ ethnic disparities exist in its use.
Studies examining temporal trends in cardiac stress testing have generally focused on patients enrolled in Medicare or other selective populations that may not be representative of the U.S. population (13) (14) (15) . To our knowledge, studies of disparities in cardiac stress testing have primarily explored differences in care between men and women (16 -19) , and the potential influence of race/ ethnicity has received little attention (20) . Examining disparities in this context is important because differences in the use (underuse) of diagnostic testing could contribute to poorer cardiovascular health outcomes observed in black patients or worsen health in Hispanic patients; these may both be exacerbated by efforts to reduce testing (21, 22) . To answer these questions, we used nationally representative data to explore trends in cardiac stress test use in the United States among patients evaluated for CHD; determine whether these trends may be attributable to shifts in population demographics, clinical risk factors, and provider characteristics; and evaluate whether racial/ethnic disparities exist in such testing.
METHODS

Data, Study Population, and Primary Outcome
We analyzed data collected in the National Ambulatory Medical Care Survey (NAMCS) and National Hospital Ambulatory Medical Care Survey (NHAMCS) from 1993 to 2010 (23). We included all visits to office-based physicians and hospital-based outpatient clinics by adults (aged Ն18 years) without a diagnosis of CHD. Performance or referral to cardiac stress testing was the primary outcome, and we identified these visits using International Classification of Diseases procedure codes 89.41 (treadmill stress test), 89.43 (bicycle ergometer stress test), and 89.44 (stress test with imaging) (24) . The survey specifically asks about tests that were "ordered or provided at this visit." Details of our methods are provided in the Supplement (available at www.annals.org).
Primary Measures
We used diagnoses and reasons for visits to identify patients with established risk factors for CHD based on the Framingham Heart Study, including hypertension, dyslipidemia, cigarette smoking, obesity, and diabetes or glucose intolerance. We also identified patients who visited the physician for chest pain (reason for visit classification codes 1050.0 and 1265.0) (24) . In addition, we created a measure for low-risk visits, defined by patients who had no clinical risk factors and did not visit the physician because of chest pain.
Race/ethnicity was determined, per NAMCS and NHAMCS instructions, according to the office or clinic's "usual practice, based on your knowledge of the patient, or from information in the medical record" (24) . We categorized patients as non-Hispanic white, non-Hispanic black, or Hispanic; other; or unknown race/ethnicity when such information was missing.
Other Measures
To further assess whether cardiac stress testing was associated with patient or provider characteristics, we extracted information on patient age, sex, insurance status (private, Medicare, Medicaid, self-pay or no charge, and other or unknown), U.S. census region (Northeast, Midwest, South, and West), urban or rural setting, and physician type (primary care, cardiology, and other), which were available only in the NAMCS. Census measures for the percentage living in poverty, median household income, and percentage of adults with a bachelor's degree were provided in the 2006 to 2010 NAMCS and NHAMCS by using each patient's ZIP code. We included these measures in subanalyses of racial/ethnic disparities.
Appropriateness of the Use of Imaging
We also assessed the appropriateness of cardiac stress testing with and without imaging using appropriate use criteria developed collaboratively by several medical specialty societies, including the American College of Cardiology, American Society of Nuclear Cardiology, and American Society of Echocardiography (25) . When adapting these criteria to our population, we generally considered a test to be rarely appropriate if it was ordered or performed in a patient without chest pain or angina as a reason for the visit or if the patient had ischemic equivalents (including jaw or shoulder pain, palpitations, and dyspnea), CHD risk equivalents, electrocardiogram abnormalities, or syncope. The NAMCS and NHAMCS provide a sufficient amount of clinical data to identify cardiac stress tests that are rarely appropriate because they collect detailed information about patients' symptoms and physicians' diagnoses. To maximize the specificity of our approach and minimize the risk for incorrectly categorizing an appropriate test as inappropriate, we also generally excluded tests that were done in patients with congestive heart failure (see Table 9 of the Supplement for a detailed description of methods). Our assessment was limited to the years 2005 to 2010, after which appropriate use criteria were adopted.
We also estimated the potential economic and health impact of inappropriate testing in the United States. To perform our economic analysis, we used average national Medicare reimbursement rates as a proxy for economic costs (26) . Because Medicare reimbursement for cardiac stress tests with and without imaging decreased from 2005 to 2010, we calculated the mean reimbursement levels between these 2 years and converted these amounts to 2013 U.S. dollars using the Consumer Price Index ($114 for stress electrocardiography, $284 for stress echocardiography, and $644 for stress myocardial perfusion imaging [MPI] ). We also assumed that 62% of stress tests with imaging in patients having initial outpatient evaluation for CHD were done with MPI, and the remainder with echocardiography (27) . Similarly, the population-attributable risk for cancer due to ionizing radiation related to stress MPI (mean effective dose, 16.9 mSv per examination) was estimated to be 1 radiation-related cancer per 1230 MPIs on the basis of a prior study that adjusted for examination technique, type of cardiac radiopharmaceutical used, and population characteristics (28). Finally, we assumed that
Context
Some observers believe that cardiac stress testing with imaging is an important source of rising health care costs and radiation exposure, but not much is known about time trends.
Contribution
This study reports a steady increase in the use of cardiac stress testing over many years. Changes in patient and provider characteristics contributed to the increase in overall testing but not to the increase in imaging, and nearly one third of imaging tests were for patients in whom such testing is rarely appropriate.
Caution
Limited clinical data prevented some types of analyses.
Implication
The reasons for doing multiple imaging tests are not well-understood.
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Physician Decision Making and Trends in the Use of Cardiac Stress Testing patients were unlikely to receive more than 1 cardiac stress test with imaging each year (29) .
Statistical Analysis
All analyses accounted for the complex sampling design of the NAMCS and NHAMCS (30). We used simple and multivariate logistic regressions with year included as a continuous linear predictor to examine time trends. We adjusted multivariate logistic regression models for patients' clinical risk factors and demographic characteristics, insurance, region, setting, and physician specialty. To determine which specific patient and provider characteristics contributed to the overall trends we observed, we constructed simple logistic regression models that assessed whether statistically significant factors in our primary model also increased in prevalence during the study period. The specifications of our models are further described in the Supplement. Analyses were done using Stata, version 12 (StataCorp).
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RESULTS
Cardiac Stress Tests
Over the 18-year period, the average annual rate of ambulatory visits in the United States resulting in a cardiac stress test being ordered or performed increased from 28 per 10 000 visits among adults without CHD in 1993 to 1995 to 42 Table 1 and Figure 1 ). Overall, there was a trend toward more frequent testing over time in unadjusted analyses (P Ͻ 0.01), but this finding was not significant after adjustment for patient characteristics, clinical risk factors, and provider characteristics (P ϭ 0.134). In particular, an increase over time in the proportion of patients who were men; were aged 45 to 64 years; had private insurance or Medicare; were seeing cardiologists or other non-primary care physicians; or were diagnosed with hypertension, dyslipidemia, diabetes, or obesity contributed to the trend.
Use of Imaging With Cardiac Stress Tests
Cardiac stress tests with imaging comprised an increasing portion of all stress tests ordered or performed over the 18-year period, increasing from 59% (CI, 50% to 69%) in 1993 to 1995, to 87% (CI, 82% to 92%) in 2001 to 2003, and to 87% (CI, 82% to 93%) in 2008 to 2010 ( Table 1 of the Supplement). This trend was not explained by changes in population demographics, risk factors, or provider characteristics (P Ͻ 0.001 for time trend after adjustment).
In our assessment of appropriateness, we found that 30% of cardiac stress tests with imaging (approximately 972 500 annual tests from 2005 to 2010) and 14% of those without imaging (approximately 67 500 annual tests from 2005 to 2010) were rarely appropriate. The most common principal diagnosis in visits with inappropriate testing was hypertension. These tests with and without imaging were associated with annual health care costs of $494 million and $7.7 million, respectively, or a total cost of $501.7 million. On the basis of these estimates, patients were exposed to up to 10.2 million mSv of unnecessary radiation each year from stress MPI-an amount that would result in 491 patients per year developing cancer later in their lifetime.
Time Trends in Subgroups
Although trends in cardiac stress test rates were not significant after adjustment in the overall population, they remained significant in the following subgroups: women (P ϭ 0.045), persons aged 65 to 79 years (P ϭ 0.008), Medicare enrollees (P ϭ 0.024), patients who presented with chest pain (P ϭ 0.033), patients who saw a cardiologist (P ϭ 0.043), or patients who had a non-low-risk visit (P Ͻ 0.01) ( Table 1 ). In contrast, our analysis of the use of imaging showed upward trends overall and in nearly every subgroup, but the trend was significant only after adjustment in white patients and patients of other or unknown race/ethnicity ( 
Racial/Ethnic Disparities
Over the 18-year study, the mean number of cardiac stress tests per 10 000 visits was 41 for white patients, 38 for black patients, 33 for Hispanic patients, and 42 for patients of other or unknown race/ethnicity ( Table 2) . We observed a general upward trend in cardiac stress test and imaging use in all racial/ethnic groups (Figure 2) . We found no evidence of a lower likelihood of black patients receiving a cardiac stress test (adjusted odds ratio [AOR], 0.91 [CI, 0.69 to 1.21]). Cardiac stress test rates were lower in Hispanic patients, but this finding did not reach statistical significance at the 5% level (AOR, 0.75 [CI, 0.55 to 1.02]). In a sensitivity analysis, we included census data on poverty, education, and income from 2006 to 2010; limited our model to only patients whose race/ethnicity was known; and used the imputed race/ethnicity in each year the NAMCS and NHAMCS provided these data. These changes did not alter our results. 
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DISCUSSION
In this analysis of national trends in cardiac stress tests performed in or ordered for adults without a diagnosis of CHD, we provide novel evidence that national growth in cardiac stress test use can largely be explained by changes in population demographics, clinical risk factors, and provider characteristics rather than changes in physicianordering behavior. In contrast to overall growth, the brisk increase in the use of imaging in cardiac stress tests was largely unexplained by these factors, and a substantial portion was for patients in whom imaging is rarely appropriate. Our examination of racial/ethnic disparities in cardiac stress testing uncovered little evidence for a difference in the likelihood of physicians using cardiac stress tests in black or Hispanic patients compared with white patients. This suggests that physician decision making on such testing does not contribute to health disparities in cardiovascular disease, although our study cannot assess the burden of unmet need among at-risk patients who did not visit physicians.
Concerns about overuse or cost-ineffective use of cardiac stress testing, particularly with imaging, are widespread (1) and have spurred intense research (13-15, 31, 32) , payer policy changes (4, 5) , and professional society action (6, 7) . The diagnostic performance and positive predictive value of cardiac stress testing have also been questioned (33) . As part of the Choosing Wisely campaign, cardiac stress testing is specifically mentioned in statements issued by the American College of Physicians (11), American Academy of Family Physicians (10), American College of Cardiology (6), and American Society of Nuclear Cardiology (9) . Because of limitations in the clinical data reported in the NAMCS and NHAMCS, we are unable to determine whether national patterns of cardiac stress test use at any time in our study represent underuse, optimal use, or overuse based on appropriateness guidelines (34) . However, we can conclude that growth in cardiac stress test use in several patient populations, including women, Medicare enrollees, patients aged 65 to 79 years, and patients with at least 1 clinical risk factor for CHD, cannot be fully explained by changes over time in population demographics, risk factors, or provider characteristics. This finding in women may reflect growing recognition of and remediation for gender disparities in cardiac testing and procedures, which has been a controversial issue over the past 20 years (16 -19, 35, 36) . Our findings in Medicare enrollees are consistent with other studies that have reported rapid growth in cardiac stress test use in this population (13, 14) . Furthermore, among the factors that contributed to the increasing overall trends, many were patient or clinical characteristics associated with an increased risk Original Research Physician Decision Making and Trends in the Use of Cardiac Stress Testing for CHD, but the independent contributions of private insurance and Medicare suggest that trends are at least partially driven by nonclinical, and possibly economic, motivations. Our findings clearly show that the use of cardiac stress tests with imaging has grown rapidly over the past 18 years in the United States and in nearly every subgroup. However, in light of our overall findings, this largely represents a substitution of imaging for nonimaging tests. Therefore, tracking cardiac stress tests with imaging alone may be a misleading metric for use. However, because these tests are done with nuclear imaging (27, 37, 38) , which is expensive and exposes patients to radiation, this trend may be a legitimate quality concern. Moreover, we found that nearly one third of cardiac stress tests with imaging were ordered for or performed in patients in whom they were rarely AOR ϭ adjusted odds ratio. * Includes only adults without a diagnosis of coronary heart disease. Trend analyses are based on logistic regression models, with adjustment for patient and provider characteristics.
† Among all visits of adults without a diagnosis of coronary heart disease and falling within a subgroup. ‡ Reference for each diagnosis category includes all visits of adults without that diagnosis.
appropriate. In addition to these inappropriate tests increasing the population risk for cancer, the associated cost of $494 million annually is important because, in the long run, it reduces society's ability to provide other health services or expand access to care for uninsured and underserved populations. Our results therefore support and further refine concerns voiced by professional societies and insurers about use. Currently, robust efforts are under way to reduce inappropriate testing and radiation exposure from necessary tests, with leadership from several professional organizations, including the American College of Cardiology, American Society of Nuclear Cardiology, and American College of Radiology (9, 39) . These organizations are actively working to reduce risks and harms related to radiologic technologies.
Racial/ethnic disparities in the diagnosis and treatment of cardiovascular disease and its risk factors are widely recognized, and reducing the burden of these disparities was a major focus of Healthy People 2010 (40). Our findings suggest that these disparities, which have been reported in the use of preventive and therapeutic cardiovascular inter- Our study has several imitations. The NAMCS and NHAMCS provide only a limited amount of clinical information on each patient visit; we often could not characterize a patient's chest pain as typical or atypical, nor were we able to distinguish cardiac stress tests with imaging done through echocardiography from those done through cardiac magnetic resonance perfusion scanning or nuclear imaging. Our estimates of attributable types of cancer and costs could also be erroneously inflated by double-counting of cardiac stress tests if tests ordered at 1 office visit and were provided at another (instead of being provided separately from an office visit, such as in a stress test laboratory), with both visits counted in the survey. To help address this concern, we estimated the portion of stress tests ordered by cardiologists (because primary care physicians are less likely to do a stress test in the office) with patients who had been seen within the past 12 months. This portion was 27.8% in 2005 to 2010, and we believe that visits specifically meeting the requirements for double-counting within this subset are uncommon and do not contribute significantly to error in our study. In addition, patients who decided not to complete ordered tests would also inflate our estimates. However, our approach to identifying inappropriate tests was conservative and most likely underestimated their overall frequency. Related to this, our findings could be sensitive to errors or anomalies in data collection or reporting, although our focus on trends may reduce the effect of these artifacts if they remained relatively stable over time. Because our study is cross-sectional, we also do not have information on patient outcomes. In addition, visits allow only 3 diagnoses, so risk factors are likely underreported for many patients and conditions. Race/ethnicity was missing for many patients and was determined by an observer instead of the patient. However, our findings did not change substantially after using multiple approaches to address this limitation. In addition, our assessment of appropriateness used stringent criteria to identify cardiac stress tests that were rarely appropriate and may have therefore underestimated the prevalence of inappropriate testing.
In conclusion, growth in cardiac stress testing can largely be explained by changes in population demographics, risk factors, and provider characteristics, but growth in the use of imaging cannot. Cardiac stress test use should continue to be examined, and understanding the incremental value of this widely disseminated technology may uncover insights into optimal approaches to further reduce the morbidity and mortality from CHD.
